Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (147)	3/29/2000 10:36:00 PM
From: scaram(o)uche	Read Replies (2) of 1833

sorry, Mike (but I don't understand the wording, as I was under the impression that the exclusive license would roll over to a non-exclusive)....... In November 1999, the Company terminated its exclusive worldwide license to issued U.S. patents relating to MEKK enzymes and U.S. and international patent applications in the field of signal transduction in human cells that it had obtained from National Jewish Center for Immunology and Respiratory Medicine. During 1999, the Company ceased providing to Massachusetts Institute of Technology ("M.I.T.") research funding for the LivingChipTM, a technology that was being co-developed by the Company and M.I.T. to miniaturize and automate the Company's hybrid yeast cell technology. In March 2000, the Company's license to M.I.T.'s LivingChipTM technology was terminated.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next